These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9022139)

  • 1. Prevention of mammary preneoplastic transformation by naturally-occurring tumor inhibitors.
    Katdare M; Singhal H; Newmark H; Osborne MP; Telang NT
    Cancer Lett; 1997 Jan; 111(1-2):141-7. PubMed ID: 9022139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
    Medina D; Kittrell FS; Oborn CJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of mammary preneoplasia. In vitro effects of a green tea polyphenol.
    Araki R; Inoue S; Osborne MP; Telang NT
    Ann N Y Acad Sci; 1995 Sep; 768():215-22. PubMed ID: 8526351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells.
    Suto A; Bradlow HL; Wong GY; Osborne MP; Telang NT
    Breast Cancer Res Treat; 1993 Sep; 27(3):193-202. PubMed ID: 8312577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of oestradiol metabolism in myc oncogene-transfected mouse mammary epithelial cells.
    Telang NT; Arcuri F; Granata OM; Bradlow HL; Osborne MP; Castagnetta L
    Br J Cancer; 1998 May; 77(10):1549-54. PubMed ID: 9635827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative growth regulation of oncogene-transformed mammary epithelial cells by tumor inhibitors.
    Telang NT; Inoue S; Bradlow HL; Osborne MP
    Adv Exp Med Biol; 1997; 400A():409-18. PubMed ID: 9547584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent estrogen responsiveness of ras oncogene-transformed mouse mammary epithelial cells.
    Suto A; Bradlow HL; Wong GY; Osborne MP; Telang NT
    Steroids; 1992 Jun; 57(6):262-8. PubMed ID: 1440696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preneoplastic transformation in mouse mammary tissue: identification and validation of intermediate biomarkers for chemoprevention.
    Telang NT; Kurihara H; Wong GY; Bradlow HL; Osborne MP
    Anticancer Res; 1991; 11(3):1021-7. PubMed ID: 1909512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nononcogenic hormone-independent alveoli produced by carcinogens in cultured mouse mammary glands.
    Schaefer FV; Tonelli QJ; Dickens MS; Custer RP; Sorof S
    Cancer Res; 1983 Jul; 43(7):3310-5. PubMed ID: 6406057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
    Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
    Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone dependent and independent mammary tumor development form N-methyl-N-nitrosourea-treated rat mammary epithelial cell xenografts in the nude mouse: multiple pathways and H-ras activation.
    Hwang SI; Guzman RC; Swanson SM; Nandi S
    Cancer Lett; 1996 Mar; 101(1):123-34. PubMed ID: 8625275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide.
    Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT
    Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and genetic properties of the p53 null preneoplastic mammary epithelium.
    Medina D; Kittrell FS; Shepard A; Stephens LC; Jiang C; Lu J; Allred DC; McCarthy M; Ullrich RL
    FASEB J; 2002 Jun; 16(8):881-3. PubMed ID: 11967232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to mammary tumorigenesis in Copenhagen rats is associated with the loss of preneoplastic lesions.
    Korkola JE; Archer MC
    Carcinogenesis; 1999 Feb; 20(2):221-7. PubMed ID: 10069457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells.
    Telang NT; Narayanan R; Bradlow HL; Osborne MP
    Breast Cancer Res Treat; 1991 Aug; 18(3):155-63. PubMed ID: 1756258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro.
    Ozbun MA; Jerry DJ; Kittrell FS; Medina D; Butel JS
    Cancer Res; 1993 Apr; 53(7):1646-52. PubMed ID: 8453637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of aberrant proliferation and induction of apoptosis in pre-neoplastic human mammary epithelial cells by natural phytochemicals.
    Katdare M; Osborne MP; Telang NT
    Oncol Rep; 1998; 5(2):311-5. PubMed ID: 9468547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
    Kumar R; Medina D; Sukumar S
    Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogen-induced phenotypic alterations in mammary epithelial cells accompanying the development of neoplastic transformation.
    Greiner JW; DiPaolo JA; Evans CH
    Cancer Res; 1983 Jan; 43(1):273-8. PubMed ID: 6401165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the oncogenes mil and ras abolishes the in vivo differentiation of mammary epithelial cells.
    Günzburg WH; Salmons B; Schlaeffli A; Moritz-Legrand S; Jones W; Sarkar NH; Ullrich R
    Carcinogenesis; 1988 Oct; 9(10):1849-56. PubMed ID: 3048764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.